Biotech Values

[biomaven0]

If pressed, I'd say the 10-15% range is what I'd be comfortable with. But unlike the TKI's, we are unlikely to find much other than safety from the Phase I, so likely it's going to be quite a while before this could be a driver of the stock.

Peter